# A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)

> **NCT00127153** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 130 (—)

## Conditions studied

- Healthy
- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** V110, pneumococcal vaccine polyvalent

## Key facts

- **NCT ID:** NCT00127153
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 130 (—)
- **Last updated:** 2015-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00127153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00127153, "A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00127153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*